purchase customization

1 Introduction to Research & Analysis Reports
1.1 Nucleic Acid-based Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Acid-based Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nucleic Acid-based Drugs Overall Market Size
2.1 Global Nucleic Acid-based Drugs Market Size: 2023 VS 2032
2.2 Global Nucleic Acid-based Drugs Market Size, Prospects & Forecasts: 2023-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Nucleic Acid-based Drugs Players in Global Market
3.2 Global Companies Nucleic Acid-based Drugs Product & Technology
4 Nucleic Acid-based Drugs Companies Profiles
4.1 Ionis Pharmaceuticals
4.1.1 Ionis Pharmaceuticals Company Summary
4.1.2 Ionis Pharmaceuticals Business Overview
4.1.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Offerings & Technology
4.1.4 Ionis Pharmaceuticals Nucleic Acid-based Drugs R&D, and Plans
4.2 Sarepta Therapeutics
4.2.1 Sarepta Therapeutics Company Summary
4.2.2 Sarepta Therapeutics Business Overview
4.2.3 Sarepta Therapeutics Nucleic Acid-based Drugs Product Offerings & Technology
4.2.4 Sarepta Therapeutics Nucleic Acid-based Drugs R&D, and Plans
4.3 Nippon Shinyaku
4.3.1 Nippon Shinyaku Company Summary
4.3.2 Nippon Shinyaku Business Overview
4.3.3 Nippon Shinyaku Nucleic Acid-based Drugs Product Offerings & Technology
4.3.4 Nippon Shinyaku Nucleic Acid-based Drugs R&D, and Plans
4.4 BioNTech
4.4.1 BioNTech Company Summary
4.4.2 BioNTech Business Overview
4.4.3 BioNTech Nucleic Acid-based Drugs Product Offerings & Technology
4.4.4 BioNTech Nucleic Acid-based Drugs R&D, and Plans
4.5 Moderna Therapeutics
4.5.1 Moderna Therapeutics Company Summary
4.5.2 Moderna Therapeutics Business Overview
4.5.3 Moderna Therapeutics Nucleic Acid-based Drugs Product Offerings & Technology
4.5.4 Moderna Therapeutics Nucleic Acid-based Drugs R&D, and Plans
4.6 CureVac
4.6.1 CureVac Company Summary
4.6.2 CureVac Business Overview
4.6.3 CureVac Nucleic Acid-based Drugs Product Offerings & Technology
4.6.4 CureVac Nucleic Acid-based Drugs R&D, and Plans
4.7 Alnylam Pharmaceuticals
4.7.1 Alnylam Pharmaceuticals Company Summary
4.7.2 Alnylam Pharmaceuticals Business Overview
4.7.3 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product Offerings & Technology
4.7.4 Alnylam Pharmaceuticals Nucleic Acid-based Drugs R&D, and Plans
4.8 Regulus Therapeutics
4.8.1 Regulus Therapeutics Company Summary
4.8.2 Regulus Therapeutics Business Overview
4.8.3 Regulus Therapeutics Nucleic Acid-based Drugs Product Offerings & Technology
4.8.4 Regulus Therapeutics Nucleic Acid-based Drugs R&D, and Plans
4.9 Miragen Therapeutics
4.9.1 Miragen Therapeutics Company Summary
4.9.2 Miragen Therapeutics Business Overview
4.9.3 Miragen Therapeutics Nucleic Acid-based Drugs Product Offerings & Technology
4.9.4 Miragen Therapeutics Nucleic Acid-based Drugs R&D, and Plans
4.10 Mina Therapeutics
4.10.1 Mina Therapeutics Company Summary
4.10.2 Mina Therapeutics Business Overview
4.10.3 Mina Therapeutics Nucleic Acid-based Drugs Product Offerings & Technology
4.10.4 Mina Therapeutics Nucleic Acid-based Drugs R&D, and Plans
4.11 NeXstar Pharmaceuticals
4.11.1 NeXstar Pharmaceuticals Company Summary
4.11.2 NeXstar Pharmaceuticals Business Overview
4.11.3 NeXstar Pharmaceuticals Nucleic Acid-based Drugs Product Offerings & Technology
4.11.4 NeXstar Pharmaceuticals Nucleic Acid-based Drugs R&D, and Plans
5 Sights by Region
5.1 By Region - Global Nucleic Acid-based Drugs Market Size, 2024 & 2032
5.2 By Region - Global Nucleic Acid-based Drugs Revenue, (2024-2032)
5.3 United States
5.3.1 Key Players of Nucleic Acid-based Drugs in United States
5.3.2 United States Nucleic Acid-based Drugs Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Nucleic Acid-based Drugs in Europe
5.4.2 Europe Nucleic Acid-based Drugs Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Nucleic Acid-based Drugs in China
5.5.2 China Nucleic Acid-based Drugs Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Nucleic Acid-based Drugs Market Size Markets, 2024 & 2032
6.2 ASO
6.3 mRNA
6.4 siRNA
6.5 miRNA
6.6 saRNA
6.7 Aptamer
7 Sights by Application
7.1 By Application - Global Nucleic Acid-based Drugs Market Size, 2024 & 2032
7.2 Genetic Disease
7.3 Cancer
7.4 Cardiovascular Diseases
7.5 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer